ACRV
Price
$1.35
Change
+$0.11 (+8.80%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
42.33M
63 days until earnings call
AURA
Price
$6.50
Change
+$0.41 (+6.72%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
403.03M
62 days until earnings call
Interact to see
Advertisement

ACRV vs AURA

Header iconACRV vs AURA Comparison
Open Charts ACRV vs AURABanner chart's image
Acrivon Therapeutics
Price$1.35
Change+$0.11 (+8.80%)
Volume$3.84K
Capitalization42.33M
Aura Biosciences
Price$6.50
Change+$0.41 (+6.72%)
Volume$1.74K
Capitalization403.03M
ACRV vs AURA Comparison Chart
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. AURA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Buy and AURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ACRV: $1.25 vs. AURA: $6.11)
Brand notoriety: ACRV and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 58% vs. AURA: 76%
Market capitalization -- ACRV: $42.33M vs. AURA: $403.03M
ACRV [@Biotechnology] is valued at $42.33M. AURA’s [@Biotechnology] market capitalization is $403.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than ACRV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while AURA’s TA Score has 7 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 3 bearish.
  • AURA’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а +13.64% price change this week, while AURA (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($403M) has a higher market cap than ACRV($42.3M). AURA YTD gains are higher at: -25.730 vs. ACRV (-79.236). ACRV has higher annual earnings (EBITDA): -84.45M vs. AURA (-91.84M). ACRV has more cash in the bank: 187M vs. AURA (174M). ACRV has less debt than AURA: ACRV (4.01M) vs AURA (19.1M). ACRV (0) and AURA (0) have equivalent revenues.
ACRVAURAACRV / AURA
Capitalization42.3M403M10%
EBITDA-84.45M-91.84M92%
Gain YTD-79.236-25.730308%
P/E RatioN/AN/A-
Revenue00-
Total Cash187M174M107%
Total Debt4.01M19.1M21%
TECHNICAL ANALYSIS
Technical Analysis
ACRVAURA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX13.29N/A
N/A
GMO US Equity III
ACIIX8.55N/A
N/A
American Century Equity Income I
MRBPX23.78N/A
N/A
BlackRock Balanced R
SWSCX18.41N/A
N/A
Schwab Small-Cap Equity
CLTAX15.50N/A
N/A
Catalyst/Lyons Tactical Allocation A

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+1.63%
ALLR - ACRV
48%
Loosely correlated
-8.10%
VERV - ACRV
40%
Loosely correlated
+8.22%
AURA - ACRV
39%
Loosely correlated
-0.57%
CCCC - ACRV
38%
Loosely correlated
-4.87%
MGNX - ACRV
37%
Loosely correlated
-3.33%
More